Real-world treatment outcome of advanced Chinese NSCLC EGFR exon 20 insertion patients.

被引：1
|
作者：
Wang, Yan
Yang, Guangjian
Li, Jun
Xu, Haiyan
Yang, Lu
Xu, Fei
Yang, Yaning
Xia, Bing
Zhu, Viola Weijia
Qiu, Weini
Ou, Sai-Hong Ignatius
机构：
[1] Chinese Acad Med Sci, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Dept Med Oncol, Natl Clin Res Ctr Canc, Natl Canc Ctr,Canc Hosp, Beijing, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Ctr Clin Lab Med, Beijing, Peoples R China
[5] Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Comprehens Oncol, Natl Canc Ctr,Canc Hosp, Beijing, Peoples R China
[6] USC Norris Cance Ctr, Los Angeles, CA USA
[7] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Sch Med, Orange, CA 92668 USA
[8] Healthy, Beijing, Peoples R China
[9] Univ Calif, Chao Family Comprehens Canc Ctr, Orange, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9043
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-World Response and Outcomes in Patients With NSCLC With EGFR Exon 20 Insertion Mutations
    Ou, Sai-Hong Ignatius
    Lin, Huamao M.
    Hong, Jin-Liern
    Yin, Yu
    Jin, Shu
    Lin, Jianchang
    Mehta, Minal
    Nguyen, Danny
    Neal, Joel W.
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (10):
  • [2] Real-world response and outcomes in NSCLC patients with EGFR exon 20 insertion mutations.
    Ou, Sai-Hong Ignatius
    Lin, Huamao Mark
    Hong, Jin-Liern
    Yin, Yu
    Jin, Shu
    Lin, Jianchang
    Mehta, Minal
    Nguyen, Danny
    Neal, Joel W.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Real-world study of NSCLC with EGFR exon 20 insertions
    Christopoulos, P.
    Grohe, C.
    Griesinger, F.
    Falkenstern-Ge, R. F.
    Krisam, J.
    Brueckner, L.
    Wermke, M.
    Misch, D.
    Hackanson, B.
    Faehling, M.
    Tufman, A.
    Janning, M.
    Schulz, C.
    Reck, M.
    Hong, J-L.
    Lin, H. M.
    Stenzinger, A.
    Thomas, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S780 - S781
  • [4] EGFR exon 20 insertion mutations in Chinese advanced non-small cell lung cancer patients: Molecular heterogeneity and treatment outcome from nationwide real-world study
    Yang, Guangjian
    Li, Jun
    Xu, Haiyan
    Yang, Yaning
    Yang, Lu
    Xu, Fei
    Xia, Bing
    Zhu, Viola W.
    Nagasaka, Misako
    Yang, Yan
    Li, Yapin
    Qiu, Weini
    Ying, Jianming
    Oug, Sai-Hong Ignatius
    Wang, Yan
    LUNG CANCER, 2020, 145 : 186 - 194
  • [5] Real-World Treatment Patterns of Patients with EGFR Exon 20 Insertion-Mutated Advanced NSCLC Treated with Amivantamab or Mobocertinib after Platinum-Based Chemotherapy
    Spira, Alexander
    Waters, Dexter
    Ran, Tao
    Vadagam, Pratyusha
    He, Jinghua
    Vanderpoel, Julie
    Donnelly, Anjali
    Lin, Iris
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E32 - E32
  • [6] Natural History and Real-World Treatment Outcomes for NSCLC Patients with EGFR Exon 20 Insertion Mutation: An IASLC- ASCO CancerLinQ Study
    Behera, M.
    Jiang, R.
    Huang, Z.
    Bunn, B.
    Wynes, M.
    Switchenko, J.
    Scagliotti, G.
    Belani, C.
    Ramalingam, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1116 - S1116
  • [7] Real-World Characteristics and Outcomes of Advanced NSCLC Patients with Exon 19 or 21 EGFR Mutations
    Winfree, K.
    Molife, C.
    Peterson, P.
    Chen, Y.
    Visseren, C.
    Beyrer, J.
    Leusch, M.
    Dimou, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S23 - S23
  • [8] A Large Asian Real-World EGFR exon 20Insertion Mutated NSCLC Dataset with Deep Genomic Characterization
    Tan, A. C.
    Lai, G. G. Y.
    Saw, S. P. L.
    Pang, M.
    Yeo, J. C.
    Alvarez, J.
    Skanderup, A. J.
    Lim, K. H.
    Takano, A.
    Tan, G. S.
    Tan, W. C.
    Chan, J. W. K.
    Teh, Y. L.
    Rajasekaran, T.
    Jain, A.
    Tan, W. L.
    Ng, Q. S.
    Kanesvaran, R.
    Lim, W. T.
    Tan, E. H.
    Ang, M. K.
    Tan, D. S. W.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S330 - S330
  • [9] EGFR exon 20 insertion mutations in patients with locally advanced or metastatic NSCLC in the German prospective, CRISP Registry real-world cohort (AIO-TRK-0315)
    Griesinger, F.
    Sebastian, M.
    Bethge, A.
    Christopoulos, P.
    Hoffknecht, P.
    Waller, C.
    Benkelmann, R.
    Jaenicke, M.
    Fleitz, A.
    Hanselmann, J.
    Hipper, A.
    Groth, A.
    Weichert, W.
    Nusch, A.
    Rauh, J.
    Fietz, T.
    Illmer, T.
    Depenbusch, R.
    Eberhardt, W. E. E.
    Thomas, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S54 - S55
  • [10] Real-world clinical treatment outcomes in Chinese non-small cell lung cancer with EGFR exon 20 insertion mutations
    Shi, Chao
    Xing, Ruyue
    Li, Mengmeng
    Feng, Junnan
    Sun, Rui
    Wei, Bing
    Guo, Yongjun
    Ma, Jie
    Wang, Huijuan
    FRONTIERS IN ONCOLOGY, 2022, 12
12345